NitroMed, Inc. Receives Revised Unsolicited Acquisition Proposal from Deerfield Management

LEXINGTON, Mass.--(BUSINESS WIRE)--NitroMed, Inc. (NASDAQ: NTMD) said today that on Friday, January 9, 2009, NitroMed received a letter from Deerfield Management increasing Deerfield’s unsolicited proposal to acquire the company from $0.50 per share in cash to $0.65 per share in cash. NitroMed also said that it is prepared to enter into discussions with Deerfield, subject to the obligations under NitroMed’s agreements with JHP Pharmaceuticals, LLC and Archemix Corp. There can be no assurance that any agreement will be reached with Deerfield for any transaction involving NitroMed.